Cargando…
Development and validation of the cancer self-perceived discrimination scale for Chinese cancer patients
BACKGROUND: To develop a Cancer Self-Perceived Discrimination Scale (CSPDS) for Chinese cancer patients and to assess its reliability and validity. METHOD: A total of 178 patients were recruited and the classical test theory was used to develop the CSPDS. Item analysis was adapted to improve the pre...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6092871/ https://www.ncbi.nlm.nih.gov/pubmed/30107802 http://dx.doi.org/10.1186/s12955-018-0984-x |
_version_ | 1783347610016284672 |
---|---|
author | Feng, Lin-sen Li, Xin-yue Wang, Hong-rong Zhan, Jing-jing Chen, Dong Wang, Yu-feng |
author_facet | Feng, Lin-sen Li, Xin-yue Wang, Hong-rong Zhan, Jing-jing Chen, Dong Wang, Yu-feng |
author_sort | Feng, Lin-sen |
collection | PubMed |
description | BACKGROUND: To develop a Cancer Self-Perceived Discrimination Scale (CSPDS) for Chinese cancer patients and to assess its reliability and validity. METHOD: A total of 178 patients were recruited and the classical test theory was used to develop the CSPDS. Item analysis was adapted to improve the preliminary version of the CSPDS, then the reliability, the validity and the acceptability of the final version of CSPDS were assessed. RESULTS: This CSPDS contained 14 items classified into 3 subscales: social withdrawal with 7 items, stigma with 4 and self-deprecation with 3. Good validity (χ(2)/df = 1.216, GFI = 0.935, AGFI = 0.903, I-CVIs> 0.80) and good reliability (Cronbach’s alpha = 0.829, Spearman-Brown coefficient = 0.827, test-retest reliability coefficient = 0.944) were found. The completion time was 6.06 ± 1.80 min. Participants who were female and reported poor self-rated health tended to have higher CSPDS scores (P < 0.05). CONCLUSIONS: The results indicated that this CSPDS could be used to assess the level of self-perceived discrimination and to preliminarily screen perceived discrimination among Chinese cancer patients, especially in Southwest China. It may provide a basis for scientific assessment of targeted patient education, psychological counseling, social interventions, and psychotherapy in the future. |
format | Online Article Text |
id | pubmed-6092871 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-60928712018-08-20 Development and validation of the cancer self-perceived discrimination scale for Chinese cancer patients Feng, Lin-sen Li, Xin-yue Wang, Hong-rong Zhan, Jing-jing Chen, Dong Wang, Yu-feng Health Qual Life Outcomes Research BACKGROUND: To develop a Cancer Self-Perceived Discrimination Scale (CSPDS) for Chinese cancer patients and to assess its reliability and validity. METHOD: A total of 178 patients were recruited and the classical test theory was used to develop the CSPDS. Item analysis was adapted to improve the preliminary version of the CSPDS, then the reliability, the validity and the acceptability of the final version of CSPDS were assessed. RESULTS: This CSPDS contained 14 items classified into 3 subscales: social withdrawal with 7 items, stigma with 4 and self-deprecation with 3. Good validity (χ(2)/df = 1.216, GFI = 0.935, AGFI = 0.903, I-CVIs> 0.80) and good reliability (Cronbach’s alpha = 0.829, Spearman-Brown coefficient = 0.827, test-retest reliability coefficient = 0.944) were found. The completion time was 6.06 ± 1.80 min. Participants who were female and reported poor self-rated health tended to have higher CSPDS scores (P < 0.05). CONCLUSIONS: The results indicated that this CSPDS could be used to assess the level of self-perceived discrimination and to preliminarily screen perceived discrimination among Chinese cancer patients, especially in Southwest China. It may provide a basis for scientific assessment of targeted patient education, psychological counseling, social interventions, and psychotherapy in the future. BioMed Central 2018-08-14 /pmc/articles/PMC6092871/ /pubmed/30107802 http://dx.doi.org/10.1186/s12955-018-0984-x Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Feng, Lin-sen Li, Xin-yue Wang, Hong-rong Zhan, Jing-jing Chen, Dong Wang, Yu-feng Development and validation of the cancer self-perceived discrimination scale for Chinese cancer patients |
title | Development and validation of the cancer self-perceived discrimination scale for Chinese cancer patients |
title_full | Development and validation of the cancer self-perceived discrimination scale for Chinese cancer patients |
title_fullStr | Development and validation of the cancer self-perceived discrimination scale for Chinese cancer patients |
title_full_unstemmed | Development and validation of the cancer self-perceived discrimination scale for Chinese cancer patients |
title_short | Development and validation of the cancer self-perceived discrimination scale for Chinese cancer patients |
title_sort | development and validation of the cancer self-perceived discrimination scale for chinese cancer patients |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6092871/ https://www.ncbi.nlm.nih.gov/pubmed/30107802 http://dx.doi.org/10.1186/s12955-018-0984-x |
work_keys_str_mv | AT fenglinsen developmentandvalidationofthecancerselfperceiveddiscriminationscaleforchinesecancerpatients AT lixinyue developmentandvalidationofthecancerselfperceiveddiscriminationscaleforchinesecancerpatients AT wanghongrong developmentandvalidationofthecancerselfperceiveddiscriminationscaleforchinesecancerpatients AT zhanjingjing developmentandvalidationofthecancerselfperceiveddiscriminationscaleforchinesecancerpatients AT chendong developmentandvalidationofthecancerselfperceiveddiscriminationscaleforchinesecancerpatients AT wangyufeng developmentandvalidationofthecancerselfperceiveddiscriminationscaleforchinesecancerpatients |